Replies to post #652 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

I had assumed a 35% (rather than 30%) 3-DAA value share for ABT-450, so there's an adjustment to be made for that.

Not opting in for US profit-sharing on ABT-493 is a good decision, IMO (#msg-106500227) and was what I expected (#msg-107024841).